Shortly after the events of Sept. 11, 2001, the U.S. government accelerated efforts on eliminating potential terrorist threats across the U.S. -including those posed by storage of chemical warfare agents and weapons. As part of that effort, the U.S. Army is destroying its VX-nerve agent stockpile in Newport, Indiana. The Army has determined that elimination of this stockpile can be achieved best by on-site destruction of the VX-nerve agent in Indiana. The plan for the wastewater resulting from the destruction process -called Newport Caustic Hydrolysate (NCH) -would be to provide off-site treatment using an existing permitted commercial treatment facility. The NCH contains high concentrations of ethyl methyl phosphonate (EMPA), methyl phosphonate (MPA) and diisopropylaminoethylthiolate ("thiolamine"). At the Army's request, DuPont conducted studies that demonstrated that the NCH wastewater could be handled safely and in an environmentally sound manner in its Secure Environmental Treatment (SET) facility in Deepwater, New Jersey. However, concerns were raised that the phosphonate compounds were not substantially removed in the treatment process.
INITIAL STUDIES
In 2004, DuPont conducted and completed Treatability and Basic Data Development Studies for the Newport program (Reich, 2004; DuPont, 2004) to demonstrate the treatability of NCH at the SET facility in Deepwater, NJ. The studies demonstrated that the SET facility could effectively treat the NCH and comply with permit parameters, including key parameters such as BOD 5 , percent BOD removal and Whole Effluent Toxicity (WET). The process utilized in this earlier study consisted of a hydrogen peroxide pretreatment prior to biological treatment at the SET facility. Concern was raised about the low levels of phosphonate removal with the original process.
OBJECTIVES OF THIS STUDY
In response to community and governmental concerns, DuPont expanded its research to pretreatment technologies for the removal of EMPA and MPA by conducting the Treatability Study for Phosphonate Removal Technology (DuPont 2005a (DuPont , 2005b . The study evaluated a number of pretreatment alternatives and assessed various aspects of the technology including phosphonate removal effectiveness and applicability at large scale. After optimization of the pretreatment process, bench-scale biotreatment tests were performed to evaluate the impact of the pretreated material on the SET facility operability and performance and on effluent quality, with a substantial focus on whole effluent toxicity. The phosphonate removal technology would be implemented as a separate pretreatment step in the SET wastewater treatment facility as illustrated in Figure 1 . 
Combined Pretreatment Oxidation Studies
H 2 O 2 pretreatment, as demonstrated in the earlier DuPont treatability studies, reduced the thiolamine content of the 8% NCH by > 99.9 % but had limited effect on the concentrations of EMPA and MPA (Reich, 2004; DuPont 2004) . Preliminary laboratory studies performed by DuPont indicated that alternative chemical oxidants such as sodium persulfate enhanced the conversion of EMPA to MPA.
Sodium persulfate, Fenton's reagent and oxidant/catalyst combinations were evaluated as alternative chemical oxidants for the conversion of EMPA to MPA prior to biotreatment. Oxidation studies were performed using standard laboratory equipment that included a four-neck flask fitted with a condenser, thermometer, pH probe, and magnetic stirrer with heating mantle. In experiments that required aeration, the air was fed sub-surface through a 22-gauge needle and the gas flow was measured with a wet test meter. Batch laboratory studies were conducted with reagent grade EMPA and 8% NCH samples to define experimental conditions that maximize the EMPA conversion. The investigations identified optimal oxidant treatment ratios, reaction temperature, and reaction time systematically through range finding experiments and optimization studies.
The chemical oxidations were evaluated on the following criteria:
1. EMPA conversion efficiency. 2. Process and operational safety. 3. Potential impact to plant operations.
EMPA and MPA concentrations of the "as received" and oxidized NCH were analyzed by ion chromatography using standard Quality Assurance and Quality Control (QA/QC) protocols. The EMPA conversion efficiency was determined from the initial and final EMPA concentrations accounting for the pH and oxidation dilution factors according to the following equation:
% EMPA Conversion = 100
Samples of oxidized 8% NCH (DIC) were utilized for the optimization of the precipitation stage of the combined pretreatment process and generated material for the biotreatability portion of the study.
Sodium Persulfate Oxidations.
Scouting studies on the sodium persulfate oxidation of EMPA were initiated using reagent grade EMPA and MPA. EMPA or MPA solutions at an initial test concentration of 20,000 mg/L were prepared in distilled water with a variable amount of sodium persulfate and were heated for a period of approximately 4 hours at 80°C. The EMPA and MPA concentrations of the oxidized solutions were determined by ion chromatography using standard Quality Assurance and Quality Control (QA/QC) protocols.
The persulfate oxidation process was validated and optimized using a sample of 8% NCH (DIC). The 8% NCH sample was analyzed by ion chromatography and contained 35,394 mg/L EMPA, 2,210 mg/L MPA and < 100 mg/L PO 4 . The pH of the NCH sample was adjusted to approximately pH 6.0 using 20% H 2 SO 4 before the oxidation reaction. An aqueous solution of sodium persulfate was mixed with the NCH sample and was heated to 80-90°C for approximately 3-4 hours. The pH at the end of the oxidation reaction was generally in the range of 0-1.0 and depended on the starting concentration of the sodium persulfate.
Sodium persulfate was an effective oxidant for both EMPA and MPA (Table 2) . Persulfate oxidation of EMPA resulted in the formation of MPA as the predominate end product. The oxidation of EMPA was shown to be quantitative with a weight ratio of 7.50 persulfate:EMPA and resulted in a decrease of the EMPA concentration from an initial value of approximately 20,000 mg/L to < 100 mg/L. MPA was more resistant than EMPA to sodium persulfate oxidation in batch studies. The oxidation of MPA with a weight ratio of 7.50 persulfate: MPA resulted in a decrease in the MPA concentration from an initial test concentration of 20,000 to 1,530 mg/L. The product of the oxidation was inorganic phosphate (PO 4 ). The addition of VTX catalyst, an iron catalyst from Advanced Oxidation Technologies, Inc., did not significantly improve the MPA oxidation in these studies. The complete conversion of EMPA to PO 4 is estimated to require a persulfate:EMPA ratio of 15.0 or higher. The conversion of EMPA to MPA was enhanced by the introduction of air in the persulfate oxidation reaction (Table 3) . The final EMPA concentration was 2253 mg/L for the standard oxidation and < 25 mg/L for the oxidation that included aeration. The optimal persulfate dose was determined to be between 0.30 and 0.5 Persulfate: NCH (wt: wt) for the standard persulfate oxidation (Table 4) . Persulfate:NCH ratios (wt:wt) of 0.25, 0.30 and 0.50 resulted in EMPA conversions of approximately 79%, 98% and >99%, respectively, and reduction in EMPA concentration from approximately 35,000 mg/L to 3727, 310 and <25 mg/L, respectively. None of the oxidations resulted in the generation of PO 4 in the final reaction mixture indicating MPA was resistant to oxidation under these reaction conditions. The pH response during the persulfate oxidation indicates there is a rapid low temperature reaction presumably involving the thiolamine to disulfide conversion. The bulk of the oxidation reaction does not appear to start until the temperature is >60°C. The first order half-life for the decomposition of persulfate is approximately 10 minutes at 90°C. The conditions for the standard oxidation reaction with aeration occur over ten half lives of the persulfate resulting in essentially a complete (>99.9%) reaction of the persulfate.
The optimization studies for the persulfate oxidation with aeration process indicated the treatment ratio of persulfate: NCH (wt:wt) for complete conversion of EMPA is approximately 0.30. The molar ratios of persulfate and EMPA in the 8% NCH sample were determined to be approximately 12.0 and 6.2, respectively. The persulfate optimization results indicate that persulfate is a relatively selective reagent under the current oxidation conditions. It is estimated to require two stoichiometric equivalents of persulfate to oxidize EMPA to MPA and acetic acid, two equivalents to oxidize the isopropyl groups on the thiolamine to acetone, and one to two equivalents to oxidize the thiol group. A mechanistic scheme for the oxidation of EMPA and MPA by persulfate is presented in Figure 3 and the reaction scheme for the oxidation of thiolamine is presented in Figure 4 .
The optimized oxidation conditions were utilized to validate the EMPA conversion efficiency of EMPA to MPA using an 8% NCH (DIC) sample that became available during the study.
Comparison of the oxidation results for the two lots of NCH based on a persulfate:EMPA ratio is presented in Table 5 , indicating similar results based on the molar ratios of persulfate and EMPA. Hydrogen peroxide. Hydrogen peroxide when used in conjunction with aeration during the oxidation reaction was found to enhance the EMPA conversion (Table 7) . NCH samples pretreated with a 0.1 ratio of 10% H 2 O 2 with a 0.25 persulfate: NCH (wt:wt) treatment ratio resulted in final EMPA concentration of <25 mg/L compared to 343 mg/L for the persulfate sample with aeration. Similar results were observed at a 0.20 persulfate: NCH treatment ratio where the residual EMPA concentration of the hydrogen peroxide pretreatment was 208 mg/L compared to 2,104 mg/L for the oxidation with aeration. (Note: Additional work showed that performance differences between air and peroxide could be effectively overcome by increasing persulfate dosage. Most of the work described herein used aeration in the persulfate oxidation step. Subsequently it was decided that peroxide addition would be more practical than aeration.)
Time requirements. The time requirements for the sodium persulfate oxidation reaction were determined using NCH at a 0.38 persulfate:NCH treatment ratio. The pH adjusted NCH sample was mixed with the persulfate solution and heated at 80-90°C with aeration at a rate of 2 ml/sec. Samples were taken at 2, 4 and 4.5 hours and analyzed by ion chromatography for EMPA, MPA and PO 4 . The product at the end of the oxidation was a colorless solution and did not contain any solids. The EMPA conversion was essentially complete within the initial time period at 2 hours (Table 8 ). There was a slight increase in the PO 4 concentration of the sample after 4 hours of oxidation. Fenton Oxidations. Fenton and persulfate oxidations were pursued simultaneously. Two Fenton systems were evaluated: (1) the traditional Fenton system of hydrogen peroxide and iron (II) sulfate at pH 2-3 and, (2) hydrogen peroxide plus the VTX iron catalyst from Advanced Oxidation Technology, Inc at a pH range of 6.0-7.5. Sodium hydroxide was added as necessary to maintain the reaction solution in the desired pH range in the VTX experiments. The Fenton reaction was considered complete when the pH of the oxidation solution remained stable. All Fenton oxidations were run at ambient temperature using pH adjusted 8% NCH. The VTX system appeared to result in higher EMPA conversions than the traditional Fenton's reaction.
The final EMPA concentration was reduced by 85 to 90% in the VTX system and 20 to 25% for the traditional Fenton's oxidation. The final MPA concentration in the VTX system was approximately half the level that was anticipated for the observed EMPA conversion.
The early success of the sodium persulfate oxidations for the essentially complete conversion of EMPA compared to the higher residual levels of EMPA in the Fenton samples led to the decision to use the remaining NCH and resources to optimize the persulfate process and suspend work on the Fenton processes. Factoring into this decision were safety issues, as there were unresolved issues of catalyst deactivation leaving residual amounts of peroxide and sudden exotherms experienced in some cases.
It is speculated that the precipitation of iron salts at the end of the reaction may have lowered the residual MPA concentration in the oxidized solution. This experiment was noteworthy in that at the end of the reaction (4 hours), on transferring the reactor contents to a bottle, the temperature suddenly rose from ambient to 50° C over several minutes, accompanied by substantial gas evolution. It is assumed that the catalyst had become deactivated, even though there was residual peroxide in the solution.
Combined Pretreatment Precipitation Evaluations
The combined pretreatment process utilizes chemical oxidation to convert EMPA to MPA and chemical precipitation to decrease the MPA concentrations prior to bio-treatment. The precipitation studies of the combined process were optimized in parallel with the oxidation studies. The studies evaluated the removal efficiency of FeCl 3 and other common wastewater chemical coagulants/flocculants in room temperature batch isotherm studies using reagent grade MPA. Optimization studies defined the optimal treatment ratio, operational pH and solids generation for the process.
Stock solutions of MPA and FeCl 3 were prepared in deionized water, and the pH of the test solutions was adjusted with 16% lime slurry after addition of all test reagents. The solids were removed by gravity sedimentation immediately after the pH adjustment step and an aliquot of the supernatant was filtered using a 0.45 μ (or smaller) syringe filter. MPA concentrations of the supernatants and stock solutions were analyzed by ion chromatography using standard Quality Assurance and Quality Control (QA/QC) protocols. The removal efficiency was determined from the initial and final MPA concentrations and the precipitation dilution according to the following equation:
Alternative Chemical Precipitation Evaluations. Laboratory studies were performed to evaluate MPA removal efficiency using the common wastewater chemical coagulants/flocculants: aluminum chloride (Al 2 Cl 3 ), aluminum sulfate (Alum) (Al 2 (SO 4 ) 3 ), ferric sulfate (Fe 2 (SO 4 ) 3 ), and ferric chloride (FeCl 3 ). Batch isotherm studies were conducted at room temperature with reagent grade treatment chemicals over a range of concentrations (1,000 to 10,000 mg/L) and pH values (6-8). Additionally, aluminum chloride and aluminum sulfate studies evaluated MPA removal efficiencies at a target pH of 4. The studies were conducted with an initial MPA concentration of 2,000 mg/L, which was based on the final MPA concentration in the preliminary oxidation studies using NCH materials.
The test solutions were prepared in deionized water using MPA and test chemical stock solutions. The pH of the test solutions was adjusted to the test pH using 16% lime slurry after addition of all test reagents. The solids were removed by gravity sedimentation immediately after the pH adjustment and volume adjustment steps and an aliquot of the supernatant was filtered using a 0.45 μ (or smaller) syringe filter. MPA concentrations of the supernatants were determined and removal efficiency calculated as described above.
All the test chemicals were effective in MPA removal at 10,000 mg/L, the highest test concentration ( Figure 5 ). Removal efficiencies ranged from approximately 94 % for the Fe 2 (SO 4 ) 3 to 99.9% for the Al 2 Cl 3. Aluminum sulfate, aluminum chloride and ferric chloride were equally effective in MPA removal at a 3000 mg/L test concentration while ferric sulfate treatment resulted in a lower MPA removal efficiency.
The optimal pH of the test solutions was similar for all of the test materials. In general, maximal MPA removal was observed at a test solution pH of 6. In most studies, the MPA removal decreased as the pH of the test solution was increased to pH 8. The lowest removal efficiencies were generally observed in the high pH (pH 10) test solutions in the FeCl 3 and Fe 2 (SO 4 ) 3 evaluations and at pH 4 and pH 10 in the Al 2 Cl 3 and Al 2 (SO 4 ) 3 evaluations for treatment levels of 3,000 and 10,000 mg/L. The 1,000-mg/L treatment level was not effective at MPA removal in these studies.
The Al 2 Cl 3 and Al 2 (SO 4 ) 3 test chemicals formed white fluffy or cloud-like solids, which did not settle rapidly and were easily re-suspended. In contrast, the FeCl 3 and Fe 2 (SO 4 ) 3 solids were brown and granular in appearance, settled readily and had a compact settled volume. 
FeCl3
DuPont SET has considerable experience in the safe handling, storage and use of thirty five percent FeCl 3 solutions. The comparable MPA removal efficiency, dense solids characteristics and extent of plant experience with FeCl 3 compared to the other test chemicals led to the selection of FeCl 3 for the combined pretreatment optimization, NCH combined pretreatment demonstrations and subsequent biotreatability evaluations.
FeCl3 Treatment Ratio Studies. The optimal treatment ratio (FeCl 3 :MPA) required for the efficient removal of MPA in the combined pretreatment technology was evaluated using room temperature batch studies and reagent grade FeCl 3 and MPA. The MPA removal was evaluated, at a higher initial test concentration of 8,000 mg/L, the anticipated MPA concentration from the oxidation stage. This study evaluated the removal of MPA by FeCl 3 at test concentrations ranging from 1,000 to 30,000 mg/L. The test solutions were prepared in deionized water using MPA and FeCl 3 stock solutions. The pH of the test solutions was adjusted using 16% lime slurry to approximately 6, after addition of all test reagents.
The solids were removed by gravity sedimentation immediately after the pH adjustment and volume adjustment steps and an aliquot of the supernatant was filtered using a 0.45 μ (or smaller) syringe filter. MPA concentrations of the supernatants were determined and removal efficiency calculated.
Treatment ratio studies demonstrated that FeCl 3 was highly effective at removing MPA from batch aqueous solutions. The addition of FeCl 3 over the test range of 1000 to 30,000 mg/L resulted in the removal of 0.4 to 99.9% of the MPA, respectively (Table 9, Figure 6 ). FeCl 3 at test concentrations of 10,000 and 20,000 mg/L resulted in the removal of 82.7 and 99.4 % of the initial MPA, respectively. The MPA removal efficiency over the range of FeCl 3 concentrations (0 to 30,000 mg/L) indicated the optimal treatment ratio for MPA removal is in the range of 1.25 to 2.5 FeCl 3 : MPA or a treatment dose of 10,000 to 20,000 mg/L FeCl 3 . This treatment ratio was utilized in subsequent optimization studies for the combined pretreatment strategy. 
NCH Combined Pretreatment Validation and Treatability Sample Generation
The combined pretreatment process was validated using 8% NCH samples with each of the three stabilizers (DIC, DCC and mixed DIC/DCC) received during the study. The NCH materials were processed using the optimized combined pretreatment process to generate material for the combined pretreatment treatability study. Table 10 shows the results of this work. The oxidation results observed with the 8% NCH (DIC/DCC) sample were similar to the 8% NCH (DIC) sample, both using a 0.38 persulfate: NCH (wt:wt) treatment ratio. This resulted in essentially complete conversion of EMPA to MPA. The DCC material required higher treatment ratios to achieve complete conversion of EMPA to MPA. A persulfate: NCH ratio (wt:wt) of 0.50 was used in order to account for the proportionately greater EMPA concentration in the sample. This treatment resulted in EMPA conversion efficiency of greater than 99.5%.
The persulfate oxidation process resulted in essentially complete conversion of EMPA to MPA of 8% NCH samples containing the DIC, DCC or mixed DIC/DCC stabilizers. The oxidation results indicated the conversion efficiency of the persulfate process was related to the initial EMPA concentration of the samples and was independent of the stabilizer used in the original NCH.
Similar samples of 8% NCH(DIC) were generated for the biotreatability testing, which is discussed later. Specific Organic Analyses. GC/MS was used to analyze the "as received", oxidized, and precipitated NCH samples containing DIC, DCC, and DIC/DCC stabilizers. As an example, the GC/MS analysis of the 8% NCH samples at each stage of the pretreatment for the NCH with the DIC stabilizer are shown in Figures 7-9. The GC/MS analyses demonstrate that the volatile and semi-volatile organic components present in the 8% NCH "as received" samples are no longer present after the persulfate oxidation stage. In the DIC material, a small amount of acetic acid was formed during the oxidation (Figure 8 ), but was not present after the precipitation stage ( Figure 9 ). In the DCC and DIC/DCC materials a small amount of diisopropylamine was formed during the oxidation stage but was not present after the precipitation stage. 
Chemical Fate of Impurities Present in NCH
VX has been reported to contain a number of impurities that would be reactive under the conditions of chemical pretreatment. Table 11 lists the principal impurities reported to be present in VX. For reasons of brevity, stoichiometry and reaction mechanisms are not included in this paper. Under the vigorous oxidative conditions it is expected that the products of the trace compounds will afford the same products as those obtained from principal components of the hydrolysate, EMPA and the thiolamine, namely MPA, acetic acid, formic acid and ammonia. The sulfur in the thiols and in the trace compounds is assumed to be oxidized to an oxo acid of sulfur, either sulfurous acid or sulfuric acid. The GC/MS analysis of the oxidized NCH samples demonstrates the absence of these trace components. Acetic and formic acids are the only oxidation products detected by GC-mass spectrum in the oxidized NCH samples. 
16% NCH Combined Pretreatment Validation and Biotreatability Sample Generation
Several months after completion of the pretreatment and biotreatability studies on 8% NCH, similar studies were undertaken on more concentrated 16% NCH. The 8% NCH studies included pretreatment validation on NCH with all stabilizers, but biotreatability on NCH with the DIC stabilizer only. As interaction with the public and regulatory agencies continued, DuPont decided that it might be more helpful to generate biotreatability results for NCH with each of the stabilizers. Therefore, this was included as part of the studies on 16% NCH.
As with the 8% NCH studies described above, the initial steps in the 16% studies included screening for effective dosages of treatment chemicals, including the sodium persulfate for EMPA and thiolamine oxidation and the ferric chloride for MPA precipitation and sorption. The findings were that dosages on a wt:wt basis were nominally doubled for the 16% NCH as compared with the 8% NCH. In fact, the persulfate dosage continued to be approximately constant on the basis of the EMPA concentration. After the dosage studies were completed, pretreated 16% NCH was generated for the biotreatability studies. Samples were oxidized using a treatment ratio of 1.08 sodium persulfate: NCH "as received" (wt:wt) and precipitated with 20,000 mg/L FeCl 3 and lime slurry at a pH of approximately 5.
The combined pretreatment process resulted in an overall volume increase, which varied slightly for the different stabilized 16% NCH test samples. The volumetric increase after combined pretreatment was 11.9, 10.4 and 10.6 for the 16% NCH DIC, DCC and DIC/DCC treatability samples, respectively (Table 11) . The combined pretreatment of 16% NCH containing the DIC, DCC and DIC/DCC stabilizers resulted in significant reductions in both the EMPA and MPA concentrations (Table 12 ). The persulfate oxidation achieved an average of > 99.7% EMPA conversion for the 16% NCH treatability samples. The MPA removal efficiency for the 16% treatability samples ranged from 95.8% for the 16% NCH DIC sample to 96.9% for the 16% NCH DCC samples. The average MPA removal efficiency for the 16% NCH treatability samples was 96.5%. The combined pretreatment technology resulted in an average overall phosphonate removal efficiency of >97.3% and a reduction in the thiolamine concentration of >99.9% for the 16% NCH treatability samples. The thiolamine concentration was reduced to less than the detection limit of 5 mg/L from an initial value of 72,400 mg/L, 34,300 mg/L and 29,700 mg/L for 16% NCH DIC, DCC and DIC/DCC, respectively. The sodium persulfate oxidation for the 16% NCH samples was as effective in thiolamine destruction as that reported for the 8% samples.
(Note that the volumetric increases explained in Table 11 were taken into account when calculating the percent conversions and removals.)
Previous biotreatability work on NCH was described in two earlier reports (Reich, 2004; DuPont, 2004) . The study described in the first report demonstrated that the SET WWTP could effectively treat NCH at the Newport Chemical Agent Disposal Facility's anticipated generation rate of 3000 to 7000 gpd of 16% hydrolysate. The study included NCH samples with DCC and with DIC. The study found the most effective treatment scheme evaluated was pretreatment of the NCH with sulfuric acid to adjust pH to 6-7 and hydrogen peroxide to control odors, followed by PACT ® biotreatment. The study demonstrated that all permit limits including BOD 5 , BOD% removal, TSS, NH3-N and acute WET testing results would be met. Hydrogen peroxide pretreatment resulted in greater than 99.9% destruction of the thiolamine. No NCH components or pretreatment daughter compounds were found in the treatability reactor effluent with the exception of EMPA and MPA. The bioreactors converted a fraction of the EMPA to MPA, but overall there was little reduction of total phosphonate components. There were no significant increases in odors for the bioreactors or the wasted biosludge cakes.
The purpose of the study described in this paper was to ascertain whether all biotreatment performance criteria, effluent permit limits and protection of the receiving water (the Delaware River) would be achieved through treating NCH in the combined pretreatment process and mixing the pretreated effluent with the remainder of the SET wastewater in its PACT® biotreatment process.
Criteria for Success. There were four criteria for judging the biotreatment of pretreated NCH to be successful. 1. Ability to maintain control of SET WWTP operations (e.g., effective dissolved organic carbon (DOC) removal, manageable foaming, pH control, solids management); 2. Ability to maintain satisfactory control of wastewater and sludge odors; 3. Ability to assure permit compliance (e.g., effluent BOD 5 , BOD 5 percent removal, effluent TSS, effluent NH3-N and acute whole effluent toxicity limits); 4. Chronic aquatic toxicity test results that demonstrate that there would be no chronic toxicity caused by NCH at the instream waste concentration (IWC).
Description of SET Wastewater Treatment Plant. The biotreatability study was performed with bioreactors and loadings that represented the SET WWTP operations. The following information briefly describes the full-scale WWTP.
The SET WWTP is an advanced industrial wastewater treatment facility that currently handles 10-15 MGD of wastewater from the manufacturing operations at the DuPont site at Chambers Works, as well as wastewater received from off-site. The range of flow rates mentioned represents the minimum and maximum monthly averages handled at the WWTP in 2003-2004. The plant was designed for and has demonstrated the capability to handle well over 30 MGD.
The WWTP also has demonstrated the flexibility to handle flow rates below 10 MGD. Operations in the WWTP include a variety of pretreatment technologies, lime neutralization, primary clarification, two-stages of PACT ® (biotreatment combined with powdered activated carbon) with clarification in each stage (see Figure 10) ; note that the figure contains a single box to depict operations to receive, pretreat and convey NCH to biotreatment.
As noted above, the monthly average flow rate at the SET WWTP typically ranges between 10 and 15 MGD. For purposes of evaluating issues involving concentrations of compounds of interest related to NCH in the wastewater, the minimum monthly average flow rate of 10 MGD is used throughout this report, so that the highest concentrations of NCH components could be evaluated. This is a conservative approach, although not excessively so. For example, if an NCH component concentration were 50 mg/L in the wastewater at the minimum flow of 10 MGD, then it would be at 33 mg/L at the maximum flow of 15 MGD. The nominal feed rates of 8% NCH used in this phase of the testing were 5000 and 10,000 gpd. When compared with the WWTP flow of 10 MGD, this yields flow ratios of 8% NCH: WWTP feed of 1:2000 and 1:1000, respectively. The same nominal volumetric feed rates were tested when the 16% NCH was studied. 
Methods
The work was conducted utilizing four trains of continuous flow Eckenfelder-type reactors, modified for PACT® addition, operated in parallel. Each reactor train was comprised of two reactors in series to simulate the first and second stages of PACT® treatment. The units were fed a combination of industrial wastewater from on and off site sources, augmented with a composite of commercial waste, both obtained from the SET facility. A control reactor system was fed only the SET industrial wastewater composite at a feed rate representative of the 10 MGD influent to the SET WWTP, as explained above. The experimental reactors for the combined pretreatment process were fed the pretreated (i.e., persulfate oxidized and ferric chloride/lime precipitated) 8% NCH at rates representing the target loading rates of 5,000 gpd and 10,000 gpd based on "as received" concentration, in addition to the SET industrial wastewater composite. Later, similar studies were undertaken with pretreated 16% NCH.
Seed biomass was obtained from SET secondary aerators and characterized for pH, MLSS, and MLVSS early in 2004 and used in earlier studies (DuPont 2004) . The seed from those reactors was used in this current study. The first stage reactor in each train was five-liters in volume. The second stage reactor in each train was 1.5 liters. All the reactors included integral clarifiers characteristic of Eckenfelder-type reactors. The three reactor trains in the 8% NCH(DIC) study were designated as follows:
• Reactor System #1 -Control two-stage PACT ® reactor receiving industrial wastewater composite at an equivalent flow rate of 10 MGD.
• Reactor System #2 -Experimental two-stage PACT ® reactor receiving combined pretreatment 8% NCH(DIC) at a rate of 5,000 gpd ("as received" basis), in addition to the Control wastewater at 10 MGD.
• Reactor System #3 -Experimental two-stage PACT ® reactor receiving combined pretreatment 8% NCH(DIC) at a rate of 10,000 gpd ("as received" basis), in addition to the Control wastewater at 10 MGD.
In the subsequent study on 16% NCH with each of the three stabilizers, the four reactor trains were designated as follows:
• Reactor System #2 -Experimental two-stage PACT ® reactor receiving combined pretreatment 16% NCH DIC at a rate of 5,000 GPD and then 10,000 GPD ("as received" basis), in addition to the Control wastewater at 10 MGD.
• Reactor System #3 -Experimental two-stage PACT ® reactor receiving combined pretreatment 16% NCH DCC at a rate of 5,000 GPD and then 10,000 GPD ("as received" basis), in addition to the Control wastewater at 10 MGD.
• Reactor System #4 -Experimental two-stage PACT ® reactor receiving combined pretreatment 16% NCH DIC/DCC at a rate of 5,000 GPD and then 10,000 GPD ("as received" basis), in addition to the Control wastewater at 10 MGD.
The goals for operational parameters for the aerobic bioreactors were set as shown in Table 13 , with the objective of simulating the first and second stage PACT ® reactors at SET.
A photograph of a typical reactor system used in the biotreatability study is provided in Figure  11 . Water to account for evaporation As needed
As needed
Figure 11 -Two-stage PACT® Test Bioreactor Set-up 1
Bioreactor effluents were routinely monitored for permit parameters. Effluents were subjected to acute WET testing to establish Fathead minnow LC50 values. Effluents from the combined pretreatment process and from the bioreactors were tested for chronic toxicity, as well. In this set of studies, three species were used: Pimephales promelas (Fathead minnow), the cladoceran Ceriodaphnia dubia and Pseudokirchneriella subcapitata (a green algae). Synthetic effluent comprised of laboratory dilution water and simple salts at concentrations approximately equivalent to the levels measured in the bioreactor effluents were also tested for chronic toxicity in order to ascertain whether simple salts in the effluent might be contributing to any chronic toxicity observed, particularly for the Ceriodaphnia.
Results
The results of these studies are presented in three parts: first, the biotreatability performance for the 8% NCH(DIC) study; second, the performance for the 16% NCH study; and finally the whole effluent toxicity (WET) results for both studies. The WET testing was such a substantial component of the NCH treatability studies that a separate section of this paper will be devoted to these tests and results.
8% NCH Study Results.
All the reactors performed very effectively throughout the duration of the study. Figure 12 shows the DOC removal efficiency for all of the reactor systems during the testing. With the exception of one data point for Reactor System #3 (11/17/2004), all systems were consistently performing at or above 80% DOC removal efficiency. The one point that was noted for Reactor System #3 occurred because of a mechanical breakdown of the mixer in the first-stage PACT ® unit on the previous day, which caused the biosolids to settle in the first-stage reactor, thereby reducing their contact with the wastewater. As can be seen, the effectiveness of the system returned immediately upon correction of the mechanical problem. Similar performance can be seen for BOD removal in Figure 13 .
For all cases, the performance of the reactors was comparably effective on these common measures of organic removal performance, DOC and BOD (as well as COD). The effectiveness of the systems can also be viewed on a concentration basis for the parameters of interest, including DOC and BOD 5 , as shown in Table 14 . Again it can be seen that the parameters of concern are quite low in most cases. The tertiary effluent BOD 5 values are all extremely low. The DOC for System #2 is slightly lower than for #3, reflecting the lower loading of NCH (the equivalent of 5,000 gpd and 10,000 gpd 8% NCH, respectively), although the COD is essentially the same. The Control is only slightly lower than the other reactors, reflecting the lower organic loading in the influent. When viewed on a percent removal basis, as in Table 15 , the differences become very minor. Although total phosphonates and MPA were monitored for these reactor systems throughout the test, and EMPA was estimated by difference, these results are not presented here because these compounds were removed in the Combined Pretreatment process to a level that was not detectable in the wastewater matrix. For example, as shown earlier (Table 10) , with the Combined Pretreatment process yielding EMPA concentrations below detection of 10 mg/L and MPA concentrations at about 160 mg/L in the pretreated 8% NCH, the concentrations in the wastewater feed would be less than 0.025 mg/L EMPA and 0.4 mg/L MPA for a loading of 5000 gpd 8% NCH, and less than 0.05 mg/L EMPA and 0.8 mg/L MPA for a loading of 10,000 gpd 8% NCH. Table 16 presents pertinent average effluent characteristics for all the reactors in comparison to the concentration-equivalent NJPDES permit limits for the SET WWTP. In all cases, the bioreactors performed well within the limits. Figure 14 presents the results of the odor panel evaluation of mixed liquors during the study period. The figure illustrates the average and the standard deviation for each mixed liquor sample evaluated by the panel. These results show that there was no significant difference between the test reactors' odor intensities and that of the control reactor. Moreover, all odor intensities were well below the level considered to require further action for odor control.
(Results from a fourth reactor are shown in this figure, representing a different pretreatment method -hydrogen peroxide addition -that was also studied. There was no significant difference in odors found for this pretreatment method compared with the Control or with the persulfate pretreatment.)
Figure 14 -Odor Panel Evaluation Results
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2 -P e r s u lf a t e /F e C l3 P r e t r m n t -5 0 0 0 g p d 3 -P e r s u lf a t e /F e C l3 P r e t r m n t -1 0 ,0 0 0 g p d , 10, 20, 40, 80, 160, 310, 625, 1250, 2500, 5,000, 10,000, 20 ,000 ppm) 16% NCH Study Results. The biotreatability portion of the study was conducted from June 10 through July 25, 2005. Prior to June 10, the three experimental reactor systems (i.e., Units #2, 3 and 4) were receiving effluent from Combined Pretreatment of 8% NCH, along with SET control wastewater, similar to operations described in the previous section of this paper. The three reactor systems were fed NCH at a rate equivalent to 5000 GPD of 8% NCH. The Control system (i.e., Unit #1) had been fed SET wastewater for several months prior to this study and continued to receive this wastewater throughout the study period.
-P e r o x id
Beginning on June 10, the three experimental reactor systems began receiving their respective pretreated 16% NCH feeds (i.e., NCH that had been stabilized with DIC, DCC and the DIC/DCC mix, respectively) at a loading rate equivalent to 2500 GPD of "as received" 16% NCH. On June 13 the rates were increased to the equivalent of 5000 GPD 16% NCH. Then on July 1 the rates were increased to the equivalent of 10,000 GPD 16% NCH.
All the reactors performed very effectively throughout the duration of the study. Figure 15 shows the DOC removal efficiency for all of the reactor systems during the testing. With the exception of one data point for the Control Reactor System (Unit #1 (7/20/2005), all systems were consistently performing at or above 85% DOC removal efficiency. There was no cause identified for the one point, but it can be seen that the effectiveness of the system returned immediately. Similar performance can be seen for BOD 5 removal in Figure 16 . In this figure it can be seen that all units consistently attained at least 99% removal of BOD 5 throughout the study period.
For all cases, the performance of the reactors was comparably effective on these common measures of organic removal performance (i.e., DOC and BOD 5 ). The effectiveness of the systems can also be viewed on a concentration basis for the parameters of interest, including DOC, COD and BOD 5 , as shown in Table 17 . Again it can be seen that the DOC, COD and BOD 5 are quite low in most cases. The tertiary effluent BOD 5 values are all extremely low. The feed DOC concentrations for the experimental bioreactor systems are somewhat higher than for the Control system, due to the additional loading of the pretreated NCH (the equivalent of 5,000 Total phosphonates, MPA and EMPA results are not presented here because these compounds were removed from the NCH in the Combined Pretreatment process to a level that is not detectable in the wastewater matrix. For example, as shown earlier in Table 12 , with the Combined Pretreatment process yielding MPA concentrations at about 160-180 mg/L in the pretreated 16% NCH, the concentrations in the wastewater feed would be about 0.8-0.9 mg/L MPA for a loading of 5000 GPD 16% NCH, and 1.6-1.8 mg/L MPA for a loading of 10,000 GPD 16% NCH. With the Combined Pretreatment process yielding EMPA concentrations below detection of 50 mg/L in the pretreated 16% NCH, the concentrations in the wastewater feed would be less than 0.25 mg/L EMPA for a loading of 5000 GPD 16% NCH, and less than 0.5 mg/L EMPA for a loading of 10,000 GPD 16% NCH.
In order to assure that the effluent MPA values were truly well below 1 mg/L, analyses were performed by the DuPont Regional Analytical Services (RAS) Laboratory on bioreactor effluent samples at two times during the course of the study. The RAS methodology employs a more sensitive Ion Chromatography (IC) method with an MDL of 0.2 mg/L MPA in the bioreactor effluents. (The RAS IC method also yields an MDL of 0.2 mg/L for EMPA in the bioreactor effluents.) Bioreactor effluents were sampled on July 1 (the final sample date for the 5000 GPD NCH loading period) and July 12 (the middle of the 10,000 GPD NCH loading period) for EMPA and MPA analysis by RAS. All effluent sample results were reported as ND (<0.2 mg/L) for EMPA and MPA. Table 19 presents average effluent characteristics for all the reactors in comparison to the NJPDES permit limits for the SET WWTP. In all cases, the bioreactors performed well within the limits. Figure 17 provides an overview of the decrease in components of interest (MPA, EMPA, phosphate and thiolamine) in the NCH through the proposed SET treatment process. This figure illustrates the results for 16% NCH(DIC). Similar figures were produced for the 8% and 16% NCH generated from agent with each of the different stabilizers. The results were all similar except that the 8% NCH concentrations were nominally about half of those shown for the 16% NCH in Figure 17 . Note that the values for the WWTP plant effluent and site outfall were calculated since they would be at levels below the level of detection. 
WHOLE EFFLUENT TOXICITY TESTING
The SET WWTP effluent is subject to Fathead minnow acute whole effluent toxicity (WET) limits of LC50 > 50% using EPA methods for acute aquatic toxicity (EPA, 2002a) . With its most recently issued NJPDES permit, the discharge is also subject to WET monitoring requirements using Fathead minnow and Ceriodaphnia using EPA methods for chronic aquatic toxicity (EPA, 2002b) . Although no limits have been set for chronic WET testing, it has been determined that the instream waste concentration (IWC) of the site discharge is about 1%. The SET WWTP discharge comprises approximately 40% of the site discharge, so the IWC for the WWTP discharge is 0.4%.
Acute Toxicity Testing
For the treatability study on 8% NCH, Fathead minnow acute toxicity testing was conducted on the PACT® biotreatability effluents twice (Table 20) . The first set of tests used a 96-hour static screening approach at a maximum waste concentration of 50%, since the permit limit was set at LC50 > 50%, and so deviated slightly from the EPA method (EPA, 2002a) . The second set of tests used a 96-hour static daily renewal approach, following the EPA method precisely. In all cases the NCH reactor effluents met the permit limit and results were at least as good as the Control reactor effluents. Two sets of Fathead minnow acute toxicity tests were also performed during the 16% NCH treatability study. The first set was performed during the 5000 gpd NCH loading period and the second set was performed during the 10,000 gpd NCH loading period. Both sets used the EPA acute WET testing method. All results gave LC50 > 100%, for the Control and all NCH test reactor effluents (Table 21) . 
Chronic Toxicity Testing
In both the 8% and 16% NCH studies, three sets of chronic toxicity studies were performed:
(1) NCH subject to the combined pretreatment process was tested without PACT® biotreatment; (2) the biotreatability study effluents were tested; and (3) a water sample with the simple salts at levels similar to the biotreatability effluents was tested. In all the chronic toxicity studies, two species -Fathead minnow and Ceriodaphnia -were tested. In addition, during the 16% NCH study, green algae was tested on the pretreated NCH.
Pretreated NCH Chronic Toxicity Results. Chronic testing was performed on effluents from the Combined Pretreatment of 8% and 16% NCH in which the agent was initially stabilized with each of the three stabilizing agents. Recognizing that reagents used in the processing add substantial salts (Na2SO4, CaCl2 and NaCl) to the matrix, the materials were mixed with laboratory dilution water to a degree equivalent to the minimum mixing the material would normally receive with the site wastewater (typically between 1:200 and 1:220 for the pretreated 8% NCH, and 1:100 and 1:110 for the pretreated 16% NCH; these ratios take into account the volume increases in the pretreated NCH as compared with the "as received" material). In order to provide more sensitivity to the test, the initial mixing with lab dilution water did not include consideration of the 2.5-fold volume increase that occurs when site noncontact cooling water is combined with treatment plant effluent. Therefore, the appropriate comparison for the NOEC results is the IWC for the treatment plant discharge, 0.4%. The NOEC dilution series was as follows: 100%, 50%, 25%, 12.5%, 6.25%, 3.1%, 1.6%, 0.8%, 0.4%. (This was used for the 8% NCH testing, but after seeing the results of this work, the series was truncated below 3.1% for the 16% NCH study.)
Chronic testing was then performed on Fathead minnow, Ceriodaphnia and (for the 16% NCH tests) green algae. Table 22 provides the chronic WET results for the two NCH concentrations and the three stabilizers at the equivalent of 10,000 gpd NCH loading for the three species. It can be seen that the NOECs for the Fathead minnow and the green algae were all 100%. The NOECs for the Ceriodaphnia ranged from 3.1% to 6.25% -all about an order of magnitude greater than the IWC. DIC/DCC 100% 6.25% 100% * All samples evaluated at the equivalent of 10,000 gpd NCH loading Chronic Toxicity Results for Pretreated and Biotreated NCH. Chronic testing was performed on effluents from the study of laboratory bioreactor treatment of SET wastewater mixed with effluent from the Combined Pretreatment of 8% NCH (DIC only) and 16% NCH (with each of the three stabilizing agents). Biotreated SET wastewater only and effluents from biotreatment of SET wastewater mixed with pretreated NCH at equivalent 5,000 and 10,000 gpd NCH loading rates were tested along with laboratory controls. Chronic WET tests were performed on Fathead minnow and Ceriodaphnia. In order to provide more sensitivity to the test, the full strength effluents used in the toxicity tests did not include consideration of the 2.5-fold increase that occurs when site noncontact cooling water is combined with treatment plant effluent. Therefore, the appropriate comparison for the NOEC results is the IWC for the treatment plant discharge, 0.4%. The NOEC dilution series was as follows: 100%, 50%, 25%, 12.5%, 6.25%, 3.1%, 1.6%, 0.8%, 0.4%. (This was used for the 8% NCH testing, but after seeing the results of this work, the series was truncated below 3.1% for the 16% NCH study.) Table 23 provides the chronic WET results for the two NCH loadings, the two NCH concentrations and the three stabilizers for the two species. It can be seen that the NOECs for the Fathead minnow varied between 12.5% and 100% for the Control effluents (i.e., effluents from biotreatment of SET wastewater alone) and likewise varied between 12.5% and 100% for the pretreated and biotreated NCH test effluents. This is about 1½ to 2½ orders of magnitude greater than the IWC. All but one of the NOEC results for the Ceriodaphnia were 25% nearly two orders of magnitude greater than the IWC. One NOEC result -at the 10,000 gpd loading of NCH(DIC) was determined to be 3.1%. However, this did not match up with the variation in NOECs for the NCH receiving pretreatment only, for which the NCH(DCC) gave the lowest results (Table 22 ). It is believed that the variation in the results is likely due to the inherent variability in the test itself. Nevertheless, even the lowest NOEC result is about an order of magnitude greater than the IWC. Goodfellow, 2000) . A number of samples of the biotreatment effluents were characterized for ionic composition during the seven-day chronic aquatic toxicity testing periods. Cations (and sulfur) were analyzed using inductively coupled plasma (ICP) spectrophotometry and anions were analyzed using ion chromatography (IC).
Alkalinity was determined via titration. The results are summarized in Table 24 . It can be seen that the addition of the pretreated NCH had little impact on the ionic composition of the biotreatment effluent, although some increases in sodium and sulfur (primarily sulfate) are evident, largely a result of the sulfuric acid and sodium persulfate additions. Note that the concentrations of many of the ions in the effluents during the 8% and 16% NCH study periods were different, but not necessarily always higher for the 16% NCH effluents. The ions indicating certain of the added reagents (again, sodium and sulfate) were higher in the 16% NCH study than the 8% NCH study. The aquatic toxicology laboratory was directed to prepare a synthetic effluent composed of laboratory dilution water with salts added based on the results listed above. The synthetic effluent composition was prepared from appropriate amounts of simple salts (NaCl, Na 2 SO 4 , KCl, MgCl 2 , CaCl 2 , NaHCO 3 ) added to deionized water. The theoretical ion compositions based on this recipe are shown in Table 25 . Chronic WET testing was performed on Fathead minnow and Ceriodaphnia over the same dilution series as for the biotreatment effluents described above. The NOEC results for the Fathead minnow were 100% for samples representing both the 8% and 16% NCH study periods (Table 26 ). The NOEC results for the Ceriodaphnia were 25% for the 8% NCH study period and 12.5% for the 16% NCH study period. Comparing the results in Table 26 to those presented in Table 23 demonstrates that the bulk of any chronic WET toxicity in the biotreatability effluents may be attributable to the simple salt composition. 
CONCLUSIONS
A number of oxidation reagents were evaluated in this study including sodium persulfate, Fenton chemistry, and other oxidant/catalyst combinations. Results indicated that EMPA conversions ranged widely based on the type and dose of reagent. Sodium persulfate was an effective oxidant and destroyed >99.9% of thiolamine. GC-MS results indicated that the oxidation removes organic components present in the NCH samples. Optimized dosage studies also resulted in nearly complete (an average of approximately 99%) conversion of EMPA to MPA. Based on laboratory studies, the sodium persulfate oxidation is a robust and manageable reaction and one that can effectively be applied at large scale operations. These studies also demonstrated that the sodium persulfate oxidation system performs equally as well with the range of stabilizers used in the chemical agent yielding the NCH (i.e., DCC, DIC, mixed DCC/DIC). The early success of the persulfate oxidations and unresolved issues of catalyst deactivation, residual peroxide levels and sudden exotherms in the VTX Fenton oxidation led to the suspension of further development with the Fenton oxidations.
Chemical removal studies on oxidized NCH demonstrated that ferric chloride was highly effective at removing MPA from batch aqueous solutions. Although some other chemical additives gave comparable MPA removal efficiencies, the dense solids characteristics and extent of plant experience with FeCl 3 compared to the other test chemicals led to the recommendation of FeCl 3 for the combined pretreatment process. Based on an optimal treatment ratio of ferric chloride doses in the range of 1.25:1 to 2.5:1 on a mass basis (FeCl3: MPA), MPA removal with NCH samples ranged from 88% to 97%. The combined pretreatment process resulted in a range of overall removal of >95% to >99% of the phosphonates when tested at optimal sodium persulfate and ferric chloride ratios in laboratory batch studies.
The biotreatability study met the stated objective and successfully demonstrated that the DuPont SET WWTP can effectively treat 8% and 16% NCH containing various stabilizers at a production rate of 10,000 GPD, while incorporating a combined pretreatment technology designed to reduce the effluent phosphonate concentration. The bioreactors performed very effectively throughout the duration of the study. DOC removals were consistently greater than 85% and averaged near 90% at both the 5,000 GPD and 10,000 GPD NCH loading rates. BOD 5 removals were at least 99% throughout the study and the bioreactors performed well within the BOD 5 WWTP discharge permit limits. Other relevant permit limits -including ammonia and acute whole effluent toxicity with Fathead minnow -were also met.
Odor evaluations on the bioreactors mixed liquors during the study period indicated that there was no significant difference between the test reactors' odor intensities and that of the control
